Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
Max Stanyard
Max Stanyard is an associate director in the research and development tax incentives team and a health care/life sciences senior analyst at RSM UK. With nearly 10 years of experience, he leads the R&D health care/life sciences team from a marketing and growth perspective. His educational background in pharmacology allows him to communicate effectively with technical staff within client organizations.